申请人:Gilead Sciences, Inc.
公开号:US20160289229A1
公开(公告)日:2016-10-06
The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D]pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.
本公开涉及调节类似受体调节剂化合物,例如二氨基吡啶并[3,2 D]嘧啶化合物和药物组合物,其中调节类似受体(例如TLR-8),以及制备和使用它们的方法。